secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2026-05-14T21:25:34+00:00
Accession:  0001140361-26-021360
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Gyre Therapeutics to Present at Shanghai Scientific Conference on May 15, 2026
------------------------------------------------------------------------------

- Gyre Therapeutics (GYRE) will present at a scientific conference in Shanghai on May 15, 2026.
- Presentation covers the company's focus on fibrosis, inflammatory diseases and cancer.
- Exhibit 99.1 furnished under Item 7.01 of Form 8-K, dated May 2026.
- Regulation FD disclosure; presentation not deemed filed for SEC liability purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000114036126021360/0001140361-26-021360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000114036126021360/ef20073544_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-021360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer